Monday, March 1, 2021

Cipla gets USFDA nod for migraine drug

Cipla gets USFDA nod for migraine drug The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline#39;s Imitrex Nasal Spray.

from Moneycontrol Business News https://ift.tt/2OhK3rC

No comments:

Post a Comment

Asian stocks open higher as Trump-Xi plan eases nerves

Asian stocks rose Friday as a planned meeting between US President Trump and Chinese President Xi Jinping eased trade tensions. Oil prices d...